News
Reliance Life Sciences Gets Subject Expert Committee's Nod for Phase 1 Trials of Proposed ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'Reliance Life Sciences gets Subject Expert Committee's nod for Phase 1 trials of proposed Protein subunit vaccine against COVID19.@ril_foundation'
Reliance Life Sciences gets Subject Expert Committee's nod for Phase 1 trials of proposed Protein subunit vaccine against COVID19.@ril_foundation pic.twitter.com/l7yzFDU89M— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) August 27, 2021
(The above story first appeared on LatestLY on Aug 27, 2021 11:34 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
